OKUR

OnKure Therapeutics, Inc. Class A Common Stock
Data: 2026-01-30
$2.64
Price
-1.65%
Change
$6.48
52W High
$1.7
52W Low

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Quick Stats
Jan 30, 2026

40.6

AI Score

HOLD

0.9

Volume Ratio

Mar 09, 2026

Next Earnings

11

+ve Days (30d)

18

-ve Days (30d)

OKUR Stock Summary

Last updated Jan 30, 2026

OKUR is currently trading at $2.64, positioned below its 200-day moving average of $2.69, suggesting bearish momentum. The stock has a 52-week range of $1.7 to $6.48.

Technical Analysis: The 50-day moving average stands at $2.93, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.535, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.492, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OKUR at 40.6/100 with a HOLD recommendation.

OKUR (OnKure Therapeutics, Inc. Class A Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 39.535
CMF (20) -0.492
ROC (10) -12.292
ADX (14) 14.263
Indicator Value
MACD (12,26,9) -0.061
AROONOSC (14) -100.0
WILLAMS %R (14) -98.514
MFI (14) 28.429
OKUR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

OKUR Price vs Max Options Open Interest
OKUR Max Change In Options Open Interest

OKUR Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OKUR Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OKUR Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OKUR Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

OnKure Therapeutics, Inc. Class A Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

OKUR Moving Averages Analysis

OKUR (OnKure Therapeutics, Inc. Class A Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 2.87
20 2.93
30 2.92
50 2.93
100 2.91
200 2.69

OKUR Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 35.8 million
Earnings/Share ($) -4.68
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.56
EPS Estimate Next Year ($) -3.725
WallStreet Target Price ($) 27
Most Recent Quarter